Serum/plasma stability evidence — ADMETatlas
Skip to content
ADMET
atlas
peptide evidence atlas
Search peptide, product, endpoint, sequence…
K
Home
Browse
Developability
Resources
About
Search atlas
K
Home
Browse
Evidence
·
Metabolic & Proteolytic Stability
Reported
Serum/plasma stability evidence
ATLXM0000175
Home
Evidence
Peptides
Products
Evidence
Context signals
Descriptors
Developability
Profile
Comparator
Resources
Manual
Explanations
Statistics
Download
License
About
Serum/plasma stability
Measurement
ATLXM0000175
Peptide
ATLPC0001635
→
Measured material
Specific molecular form
Endpoint
Serum/plasma stability
→
ADMET domain
Metabolic & Proteolytic Stability
Value
Observation
Slightly lower stability than TXIB
Evidence role
Reported: reviewed reported observation that should not be pooled as a comparable value yet
Assay / model
RP-UPLC · human · Male AB human serum
Condition
Dose/window: 100 μM · Time: Aliquots of each peptide were taken out at 0, 12, 24, 36, and 48 h. · Male AB human serum protease · In Vitro
Scientific source
DOI: 10.3390/md18040180
Source: PEPlife2
Open DOI
Manual
Explanations
Statistics
Download
About
Stack
© 2026 ADMETatlas, an academic peptide ADMET evidence atlas.
